$OMDA

Cook Steven L. sold $55K of OMDA

Cook Steven L. (Chief Financial Officer) sold 2,900 shares of Omada Health, Inc. (OMDA) at an average of $19.02 ($19.00–$19.02) across 2 trades over 2026-06-24 to 2026-06-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cook Steven L.
Published Jun 26, 2026, 11:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 26, 2026, 11:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The disclosure updates the insider activity record but does not introduce new operational or financial information. Any market reaction is likely limited to short-term sentiment around insider selling.

02

Market read

Traders may note the CFO’s ongoing selling activity, but the pre-arranged 10b5-1 nature and small dollar amount reduce decision impact.

03

What to watch

The article provides no information on performance, guidance, or changes in business fundamentals—so traders should avoid over-weighting the sale versus other catalysts.

Relevance 2/10Novelty 3/10Timing: after-hours/filing timestamp (2026-06-26) for the Form 4 disclosure

Background

This is an SEC Form 4 insider transaction: CFO Steven L. Cook sold 2,900 shares of Omada Health (OMDA) in two trades at ~$19.00–$19.02 under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health CFO Steven L. Cook filed an open-market sale of 2,900 shares at ~$19.01 under a 10b5-1 plan, disclosed via Form 4.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a pre-arranged 10b5-1 open-market sale with modest dollar value (~$55k) and no accompanying fundamental catalyst or guidance change.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None.

None.

Counterpoint

Because it’s a 10b5-1 plan, the sale may be purely mechanical (tax/compensation liquidity) and not a bearish signal.

Key entities

  • Omada Health, Inc.

    Subject of the Form 4 insider transaction; CFO Steven L. Cook sold shares under a 10b5-1 plan.

  • Steven L. Cook

    Omada Health CFO; executed open-market sales totaling ~$55.1k across 2 trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch